Work

ADVL1513: Results of a phase 1 trial of entinostat, an oral histone deacetylase inhibitor, in pediatric patients with recurrent or refractory solid tumors.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.10556

Authors: Suman Malempati, Bill H. Chang, Joel M. Reid, Xiaowei Liu, Charles G. Minard, Charles Keller, Elizabeth Fox, Brenda Weigel

Institutions: Oregon Health & Science University, Doernbecher Children's Hospital, Mayo Clinic, Children's Oncology Group, Baylor College of Medicine, Children's Cancer Therapy Development Institute, Children's Hospital of Philadelphia, University of Minnesota

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890198273

Cites:

Cited by: 6

Related to: 10